BioGenes and Eurofins Munich form HCP analysis partnership

BioGenes specialises in highly sophisticated and customized antibody and immunoassay development

BioGenes, a global leader in host cell protein (HCP) assay development, has entered into a collaboration with Eurofins BioPharma Product Testing Munich (Eurofins Munich), an internationally renowned contract research organisation for (bio)pharmaceutical product-testing and centre of excellence for bioassays, to serve as its preferred partner for HCP related impurity testing.

BioGenes will provide generic 360-HCP kits and specific HCP assay development services, as well as related 2D electrophoresis (2D-DIGE) and concomitant antibody preparation. Eurofins Munich will provide complementary analytical services to BioGenes that span the complete product development cycle from lead discovery to late stage clinical development.

Eurofins BioPharma Product Testing Munich, in co-operation with BSL Bioservice Scientific Laboratories Munich, supports its clients in the fields of bioassays, microbiology, in vitro toxicology, pharmacology and biocompatibility. Immunoanalytical and bioanalytical studies are offered as support of non-clinical and clinical programmes. Eurofins BioPharma Product Testing covers the whole range from standardised tests to special requirements and tailor-made studies.

With a strong dedication to quality and customer service since its foundation in 1992, BioGenes is the trusted and experienced immunoassay expert and a well-respected partner for leading pharmaceutical and biotech companies worldwide.

Companies